BioMarin Pharmaceutical
BMRN
#1484
Rank
โ‚ฌ9.96 B
Marketcap
51,97ย โ‚ฌ
Share price
0.60%
Change (1 day)
-38.71%
Change (1 year)

Revenue for BioMarin Pharmaceutical (BMRN)

Revenue in 2024 (TTM): โ‚ฌ2.65 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's current revenue (TTM ) is โ‚ฌ2.50 Billion. an increase over the revenue in the year 2023 that were of โ‚ฌ2.18 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for BioMarin Pharmaceutical from 1999 to 2024

Annual revenue

Year Revenue Change
2024 โ‚ฌ2.74 B25.32%
2023 โ‚ฌ2.18 B12%
2022 โ‚ฌ1.95 B19.86%
2021 โ‚ฌ1.63 B7.78%
2020 โ‚ฌ1.51 B-0.57%
2019 โ‚ฌ1.52 B16.7%
2018 โ‚ฌ1.30 B19.06%
2017 โ‚ฌ1.09 B3.11%
2016 โ‚ฌ1.06 B30.46%
2015 โ‚ฌ0.81 B31.85%
2014 โ‚ฌ0.61 B55.42%
2013 โ‚ฌ0.39 B4.92%
2012 โ‚ฌ0.37 B11.38%
2011 โ‚ฌ0.33 B20.14%
2010 โ‚ฌ0.28 B24.84%
2009 โ‚ฌ0.22 B6.85%
2008 โ‚ฌ0.21 B154.7%
2007 โ‚ฌ83.26 M30.48%
2006 โ‚ฌ63.81 M194.51%
2005 โ‚ฌ21.66 M
2002 โ‚ฌ13.31 M13.76%
2001 โ‚ฌ11.7 M-10.54%
2000 โ‚ฌ13.08 M88.63%
1999 โ‚ฌ6.93 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ0.49 B-80.37%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ50.76 M-97.97%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.29 B-88.36%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ42.12 B 1,580.51%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚ฌ0.46 B-81.49%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.43 B-82.77%๐Ÿ‡บ๐Ÿ‡ธ USA